Health Condition 1: G808- Other cerebral palsy
Conditions
Interventions
Intervention1: INTERVENTION ARM: After baseline evaluation, the subjects in the intervention arm will be started on trihexyphenidyl according to weight maximum dose upto 1mg/kg/day in divided 3 doses
Sponsors
Abhishek S
Eligibility
Inclusion criteria
Inclusion criteria: Residents of Delhi NCR
Exclusion criteria
Exclusion criteria: 1.Children who have received Trihexyphenidyl, any other anti-cholinergic or levodopa in last 3 months. 2.Children who have required titration in their baclofen dosage in last 3 months. 3.Poorly controlled epilepsy. 4.Diagnosed cases of Glaucoma or Congenital Heart block. 5.History of allergy or adverse reaction to anti-cholinergic drugs in the past. 6.History of orthopedic surgery or botulinum injection in last 6 months. 7.Presence of features of contractures or hip dislocation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| OUTCOME VARIABLES Change in score on Global Dystonia Scale. Change in score on Gross Motor Function Measure-88 (GMFM-88). Fine motor/perceptual sub scale of Early Developmental Profile 2 (EDP-2).Timepoint: Follow Up would be done at 3 weeks and 6 weeks and final assessment would be done after 12 weeks during which all the scales would be re administered. | — |
Secondary
| Measure | Time frame |
|---|---|
| OUTCOME VARIABLES Change in score on Global Dystonia Scale. Change in score on Gross Motor Function Measure-88 (GMFM-88). Fine motor/perceptual sub scale of Early Developmental Profile 2 (EDP-2).Timepoint: Follow Up would be done at 3 weeks and 6 weeks. Final assessment would be done after 12 weeks during which all the scales would be re administered. | — |
Countries
India
Contacts
Public ContactAbhishek
Maulana Azad Medical College
Outcome results
None listed